Attorney Dkt. N0. 066964-8034.USOO
`
`COMBINATION OF MAGNETIC AND ELECTROMAGNETIC
`
`TREATMENT METHOD
`
`PRIORITY CLAIM
`
`[0001]
`
`This Application
`
`is
`
`a Continuation-in-Part
`
`of US. Patent
`
`Application No. 15/178,455 filed June 9, 2016 and now pending; which is a
`
`Continuation-in-Part of US. Patent Application No. 15/151,012 filed May 10,
`
`2016 and now pending; which is a Continuation-in-Part of US. Patent
`
`Application No. 15/099,274 filed April 14, 2016 and now pending; which is a
`
`Continuation-in-Part of US. Patent Application No. 15/073,318 filed March 17,
`
`1O
`
`2016 and now pending; which is a Continuation-in-Part of US. Patent
`
`Application No. 14/951,093 filed November 24, 2015 and now pending; which is
`
`a Continuation-in-Part of. US. Patent Application No. 14/926,365 filed October
`
`29, 2015 and now pending; which is a Continuation-in-Part of US. Patent
`
`Application No. 14/789,658 filed July 1, 2015 and now pending; which is a
`
`15
`
`Continuation-in-Part of US. Patent Application No. 14/789,156 filed July 1,
`
`2015 and now pending. This Application is also a non-provisional of US.
`
`Provisional Patent Application No. 62/357,679 filed July 1, 2016 and now
`
`pending. The above-listed Applications are incorporated herein by reference.
`
`20
`
`FIELD OF THE INVENTION
`
`[0002]
`
`The present invention generally relates to combined methods for
`
`enhancing an appearance of a human body.
`
`In particular, the invention relates
`
`66964-8034.US00/134002774.1
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`to controlled treatment of target areas of the human body using treatment by
`
`magnetic field in combination with treatment by electromagnetic field, especially
`
`optical electromagnetic waves. The treatment by magnetic field uses an
`
`influence of magnetic and induced electric field on biological structure. The
`
`magnetic field is time-varying and high powered therefore the method is based
`
`on a value of magnetic flux density sufficient to induce at least partial muscle
`
`contraction.
`
`BACKGROUND OF THE INVENTION
`
`[0003]
`
`Aesthetic medicine comprises all medical procedures that are
`
`1O
`
`aimed at improving visual appearance and satisfaction of a patient. Patients not
`
`only want to be in good health, they also want to minimize all
`
`imperfections
`
`including body shape and effects of natural aging.
`
`Indeed, patients request
`
`quick, non-invasive procedures providing satisfactory results with minimal risks.
`
`[0004]
`
`The most common methods used for non-invasive aesthetic
`
`15
`
`medicine applications are based on application of mechanical waves, e.g.
`
`ultrasound
`
`or
`
`shock wave
`
`therapy;
`
`or
`
`electromagnetic waves,
`
`e.g.
`
`radiofrequency treatment or light treatment, such as intense pulsed light or laser
`
`treatment. The effect of mechanical waves on tissue is based especially on
`
`cavitation, vibration and/or heat
`
`inducing effects. The effect of applications
`
`20
`
`using electromagnetic waves is based especially on heat production in the
`
`target biological structure.
`
`[0005]
`
`Skin is composed of three basic elements: epidermis, dermis and
`
`hypodermis or so called subcutis. The outer and also the thinnest layer of skin
`
`66964-8034.US00/134002774.1
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`is the epidermis. The dermis consists of collagen, elastic tissue and reticular
`
`fibers. The hypodermis is the lowest layer of the skin and contains hair follicle
`
`roots,
`
`lymphatic vessels, collagen tissue, nerves and also fat
`
`forming a
`
`subcutaneous white adipose tissue (SWAT). The adipose cells create lobules
`
`which are bounded by connective tissue, fibrous septae (retinaculum cutis).
`
`[0006]
`
`Another part of adipose tissue, so called visceral fat,
`
`is located in
`
`the peritoneal cavity and forms visceral white adipose tissue (VWAT) located
`
`between parietal peritoneum and visceral peritoneum, closely below muscle
`
`fibers adjoining the hypodermis layer.
`
`1O
`
`[0007]
`
`Currently used aesthetic applications based on application of
`
`electromagnetic waves heat up the adipose cell over physiological temperature
`
`to induce adipose cell apoptosis and/or lysis. On the other hand the metabolism
`
`of the treated adipose cells is long-lasting. Additionally the lysed fat cell may
`
`result in local inflammation or a swelling may occur. Moreover, application of
`
`15
`
`electromagnetic waves may reduce the only adipose cells. Furthermore, skin
`
`laxity may occur after treatment by electromagnetic waves. As a result, new
`
`methods are needed to enhance the visual appearance of the patient.
`
`SUMMARY OF THE INVENTION
`
`[0008]
`
`The present device and method use a combination of non-
`
`20
`
`invasive, preferably contactless, applications of different methods for enhancing
`
`human appearance. Particularly,
`
`the present
`
`invention uses a combined
`
`treatment by time-varying magnetic field and optical waves.
`
`66964-8034.US00/134002774.1
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`[0009]
`
`The treatment is defined by application of electromagnetic waves
`
`of wavelength in the range of 635 to 1100 nm, with maximal power flux density
`
`up to 100 W/cmz. Alternatively,
`
`in the case of pulse light, the power flux density
`
`may be up to 100 W/cm2 with light pulses lasting up to 300 ms, however,
`
`preferably in the range of 1
`
`to 20 ms. Optical
`
`treatment may be used for
`
`inducing heat generation within
`
`the
`
`adipose
`
`cells over
`
`physiological
`
`temperature.
`
`[0010]
`
`The treatment by optical waves may be combined with application
`
`of magnetic treatment inducing at least partial muscle contraction. The method
`
`1O
`
`is enabled by peak to peak magnetic flux density on the coil surface of at least
`
`0.1, 0.5, 0.8, 1.5, 2, 2.4 or up to 7 Tesla; repetition rate of magnetic pulses at
`
`least 1, 10, 30, 50, 70 or up to 700 Hertz with treatment/successive treatments
`
`lasting several seconds or longer, e.g. at least 2, 5, 10, 30, 60, 120 or 240
`
`seconds, or longer. The pulse width is in the range of tens to hundreds of us,
`
`15
`
`preferably in the range of 100 to 600 us, most preferably in the range of 250 to
`
`350 us.
`
`[0011]
`
`The presented methods enable aesthetic applications providing
`
`significant reduction of number and/or volume of adipose cells and cause
`
`circumferential reduction Le. a reduction of the size of the treated body area.
`
`20
`
`Furthermore, the treatment method induces at least partial muscle contraction
`
`to provide muscle toning, muscle shaping, body contouring, body shaping or
`
`skin tightening effect. Additionally, strong muscle contractions at high repetition
`
`rate may cause mechanical movement of all
`
`the layers in proximity of the
`
`66964-8034.US00/134002774.1
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`contracted muscle. The method therefore may cause remodeling and/or
`
`neogenesis of the collagen and elastin fibers.
`
`[0012]
`
`Moreover the present methods enable additional favorable effects,
`
`such as pain relieving effect or stimulating effect. The spirit of combined effect
`
`is treatment by at least two different methods inducing the treatment effect by
`
`different process.
`
`In particular the combination of optical waves treatment and
`
`magnetic field treatment is described.
`
`BRIEF DESCRIPTION OF THE DRAWINGS
`
`[0013]
`
`Figure 1
`
`illustrates a combined treatment administered by two
`
`1O
`
`separate devices.
`
`[0014]
`
`Figures 2a and 2b illustrate a combined treatment administered by
`
`one device including a plurality of applicators comprising magnetic field
`
`generating device or optical waves generating device.
`
`[0015]
`
`Figures 3a and 3b illustrate a combined treatment by one device
`
`15
`
`including one applicator comprising at
`
`least one magnetic field generating
`
`device and at least one optical waves generating device.
`
`[0016]
`
`Figures 4a and 4b illustrate a combined treatment with optical
`
`waves generating device powered by magnetic field generated by magnetic
`
`field generating device.
`
`20
`
`LIST OF REFERENCE NUMBERS
`
`1
`
`2
`
`3
`
`optical treatment device
`
`energy source
`
`hardware panel for optical treatment
`
`66964-8034.US00/134002774.1
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`29
`
`30
`
`31
`
`32
`
`33
`
`optical waves generating device
`
`optical treatment applicator
`
`magnetic treatment device
`
`energy source
`
`hardware panel for magnetic treatment
`
`magnetic field generating device
`
`magnetic treatment applicator
`
`combined treatment device
`
`energy source
`
`hardware panel for optical treatment
`
`optical waves generating device
`
`optical treatment applicator
`
`hardware panel for magnetic treatment
`
`magnetic field generating device
`
`magnetic treatment applicator
`
`combined treatment device
`
`energy source
`
`hardware panel
`
`optical waves generating device
`
`optical treatment applicator
`
`magnetic field generating device
`
`magnetic treatment applicator
`
`combined treatment device
`
`energy source
`
`hardware panel for optical treatment
`
`optical waves generating device
`
`applicator
`
`hardware panel for magnetic treatment
`
`magnetic field generating device
`
`combined treatment device
`
`66964-8034.US00/134002774.1
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`34
`
`35
`
`36
`
`37
`
`38
`
`39
`
`40
`
`41
`
`energy source
`
`hardware panel
`
`optical waves generating device
`
`magnetic field generating device
`
`applicator
`
`magnetic field generating device
`
`conductor loop
`
`light source
`
`GLOSSARY
`
`[0017]
`
`Hardware panel refers to at least one hardware component used
`
`for controlling the optical and/or magnetic treatment. The hardware panel
`
`includes at least one of input interface for inputting treatment parameters by an
`
`operator and processing unit
`
`for controlling the optical and/or magnetic
`
`treatment.
`
`[0018]
`
`Treatment parameters refer to one or more of: magnetic flux
`
`density, repetition rate, impulse duration, wavelength, power flux density and/or
`
`1O
`
`energy flux density of the optical waves, pulse width, modulation,
`
`treatment
`
`protocol or treatment duration.
`
`[0019]
`
`Optical waves include electromagnetic waves from ultraviolet,
`
`visible and infrared spectrum ranges, i.e. the waves of wavelength in the range
`
`of 190 to 13000 nm.
`
`66964-8034.US00/134002774.1
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`[0020]
`
`Optical waves generating device refers to laser or laser diode,
`
`light emitting diode (LED), electric discharge source,
`
`incandescent source,
`
`fluorescent source, luminescent source, electroluminescent source etc.
`
`[0021]
`
`Optical treatment refers to treatment by optical waves.
`
`[0022]
`
`Target biological
`
`structure
`
`refers
`
`to a
`
`cell,
`
`a neuron,
`
`a
`
`neuromuscular plate, a nerve, a muscle fiber or a muscle, a filament, a tissue,
`
`an organ, an adipose cell, a collagen, an elastin, a skin, a pigment or a
`
`chromophore.
`
`[0023]
`
`Impulse refers to a single magnetic stimulus.
`
`1O
`
`[0024]
`
`Pulse refers to a period of stimulation by a time-varying magnetic
`
`field of at least one magnetic stimulus and time duration of no stimulation,
`
`i.e.
`
`time duration between two impulses from rise/fall edge to next rise/fall edge.
`
`[0025]
`
`Repetition rate refers to the frequency of firing the pulses;
`
`it
`
`is
`
`derived from the time duration of a pulse.
`
`15
`
`[0026]
`
`Envelope refers to shape of curve created by connection of
`
`induced energy amplitudes stimulating the target biological structure.
`
`[0027]
`
`Induced energy refers to energy stimulating the target biological
`
`structure. The amount of
`
`induced energy corresponds to repetition rate,
`
`magnetic flux density and impulse duration.
`
`20
`
`[0028]
`
`Repetition frequency refers to frequency of repeating the envelope
`
`shape; it is derived from a period of an induced energy envelope.
`
`[0029]
`
`Enhancing visual appearance refers to remodeling, reducing the
`
`volume and/or number of adipose cells, cellulite treatment, body shaping and/or
`
`66964-8034.US00/134002774.1
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`contouring, muscle toning, breast
`
`lifting, buttock lift,
`
`lip enhancement, skin
`
`tightening, skin rejuvenation, wrinkles and/or stretch mark reduction, mole mark
`
`removal,
`
`tattoo removal, hair removal,
`
`treatment of vascular lesions, acne
`
`treatment, sweating reduction and other appearance improving and/or pain
`
`relief treatment without contacting the skin.
`
`DETAILED DESCRIPTION
`
`[0030]
`
`During the last few decades the number of patients suffering from
`
`obesity rapidly increased. Due to this fact there is a need for improved devices
`
`and applications reducing number and/or volume of adipose cells of the patient.
`
`1O
`
`[0031]
`
`The present invention may be used for remodeling the adipose
`
`cells, body shaping and/or contouring, muscle toning, skin tightening, skin
`
`rejuvenation, wrinkle removing, reducing stretchmarks, breast lifting, buttock lift,
`
`lip enhancement or treatment of cellulite in general by application of combined
`
`treatment to target structure to selectively treat the target tissue.
`
`15
`
`[0032]
`
`Optical
`
`treatment may selectively heat
`
`the target biological
`
`structure. Hence optical treatment may remove and/or remodel adipose tissue.
`
`Before/after, with some overlap or simultaneously the magnetic treatment of the
`
`target biological structure may induce at least partial muscle contraction within
`
`the target biological structure to remodel the adipose tissue by natural adipose
`
`20
`
`tissue catabolism. Adipose tissue catabolism may be caused by apoptosis
`
`and/or necrosis of the adipocytes. The muscle contraction caused by induced
`
`eddy current is equivalent to a natural contraction. The adipose tissue may be
`
`reduced in natural way. Additionally, the muscle may be toned and/or shaped in
`
`66964-8034.US00/134002774.1
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`a natural way. Therefore the effect resulting in body shaping and/or contouring
`
`may be significantly improved.
`
`[0033]
`
`The present methods provide advanced approaches in aesthetic
`
`applications. Combined methods of
`
`treatment by optical
`
`treatment and
`
`treatment by magnetic field are used. The optical
`
`treatment may include
`
`treatment by optical waves. The magnet
`
`treatment may be provided by
`
`permanent magnets, electromagnetic devices generating a static magnetic field
`
`or preferably by magnetic devices generating time-varying magnetic field. In the
`
`preferred application the method may combine treatment by a pulsed magnetic
`
`1O
`
`field and optical
`
`treatment. The application is not
`
`limited by the recited
`
`combination so the combined method may include magnetic treatment and any
`
`treatment by electromagnetic field such as
`
`radiofrequency waves,
`
`e.g.
`
`microwaves, short waves or long waves.
`
`[0034]
`
`The basic parts of
`
`the optical
`
`irradiation system include a
`
`15
`
`hardware panel and an optical waves generating device or multiple optical
`
`waves generating devices. The optical waves generating device may be
`
`arranged in an array. The optical waves generating devices may be attached to
`
`each other or alternatively be individually mounted on dedicated supports. A
`
`scanning system may also be one of the options.
`
`20
`
`[0035]
`
`At least one optical wave generating device and a magnetic field
`
`generating device are provided. An optical treatment device may include at
`
`least one energy source and/or connection to the energy source, a hardware
`
`panel
`
`for controlling the optical
`
`treatment device and an optical waves
`
`66964-8034.US00/134002774.1
`
`10
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`generating device. Non limiting examples of optical waves generating device
`
`that may be used include light emitting diodes,
`
`lasers,
`
`laser diodes, different
`
`types of lamps and filtered lamps or combinations thereof. The treatment device
`
`may include at least one optical waves generating device, more preferably a
`
`plurality of optical waves generating devices of wavelength from ultraviolet,
`
`visible and infrared spectrum ranges. The wavelength may be in the range of
`
`190 to 13000 nm, preferably in the range of 290 to 3000 nm, more preferably in
`
`the range of 400 to 1500 nm, even more preferably in the range of 550 to 1450
`
`nm, particularly wavelengths about 915, 1064, 1208 and 1715 nm may be used.
`
`1O
`
`[0036]
`
`The plurality of optical waves generating devices may generate
`
`optical waves simultaneously. The plurality of generated optical waves may
`
`interfere. Alternatively the plurality of optical waves generating devices may
`
`generate a plurality of independent optical waves at different times, preferably
`
`in sequences. The plurality of optical waves generating devices may be
`
`15
`
`arranged in a predefined pattern within an applicator, e.g.
`
`in an array or a
`
`matrix.
`
`[0037]
`
`The optical treatment applicator may be preferably external (e.g.
`
`hand-held). Alternatively, the optical treatment applicator may be an integral
`
`part of the optical treatment device (e.g. chair/bed implemented). Additionally,
`
`20
`
`optical delivery elements, such as optical waveguides, light tubes or optical gel,
`
`may be used.
`
`[0038]
`
`A magnetic treatment device may include at
`
`least one energy
`
`source and/or connection to the energy source, at least one switching device, at
`
`66964-8034.US00/134002774.1
`
`11
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`least one energy storage device, e.g. a capacitor, and at least one magnetic
`
`field generating device, e.g. a coil. The generated magnetic field may be time
`
`varying, preferably pulsed. The magnetic treatment is provided by a peak to
`
`peak magnetic flux density on the coil surface of at least 0.1, 0.5, 0.8, 1, 1.5, 2,
`
`2.4 or up to 7 Tesla at repetition rate of at least 0.1, 0.5, 1, 10, 30, 50, 55, 60,
`
`80 or up to 700 Hertz with treatment/successive treatments lasting several
`
`seconds or longer, e.g. at least 5, 10, 30, 60, 120 or 240 seconds, or longer.
`
`The pulse width is in the range of tens to hundreds of us, preferably in the
`
`range of 100 to 600 us, most preferably in the range of 250 to 350 us. The
`
`1O
`
`magnetic treatment may vary the amplitude,
`
`repetition rate and/or impulse
`
`duration during the treatment, i.e. the magnetic treatment may be modulated in
`
`amplitude domain, repetition rate domain and/or in impulse duration domain.
`
`The shape of the magnetic treatment may be adjusted following the patient’s
`
`needs.
`
`15
`
`[0039]
`
`The treatment device may include a plurality of magnetic field
`
`generating devices. The plurality of magnetic field generating devices may
`
`generate the magnetic field simultaneously at the same time. The plurality of
`
`generated magnetic fields may interfere. Alternatively the plurality of magnetic
`
`field generating devices may generate a plurality of independent magnetic fields
`
`20
`
`in different
`
`time, preferably in sequences. The plurality of magnetic field
`
`generating devices may be arranged in a predefined pattern within an
`
`applicator, e.g. in an array or a matrix.
`
`66964-8034.US00/134002774.1
`
`12
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`[0040]
`
`The magnetic stimulation device may or may not
`
`include a
`
`magnetic core. The magnetic stimulation device may be cooled by a fluid, e.g.
`
`by a liquid or a gas.
`
`In the preferred embodiment the magnetic stimulation
`
`device is cooled by air. Total power consumption of the magnetic stimulation
`
`device may be below 1.3 kW. A magnetic stimulation device as described in the
`
`US patent application No. 14/789,156 or US patent application No. 14/789,658
`
`may be used.
`
`[0041]
`
`The magnetic treatment applicator may be an integral part of the
`
`treatment device, or it may be preferably external part of the treatment device
`
`1O
`
`(e.g. hand-held), alternatively the magnetic treatment applicator may be an
`
`integral part of the magnetic treatment device (e.g. chair/bed implemented).
`
`[0042]
`
`The energy source for the magnetic and/or light treatment device
`
`may be preferably external, e.g. a plug. Alternatively the energy source may be
`
`incorporated in the device, e.g. a battery.
`
`15
`
`[0043]
`
`According to one embodiment the magnetic treatment and optical
`
`treatment may be provided by at least two separate devices,
`
`i.e. at least one
`
`device for administering the magnetic treatment and at least one device for
`
`administering the optical treatment. The optical treatment may be applied to
`
`target biological structure prior, after or with some overlay with magnetic
`
`20
`
`treatment. Alternatively optical treatment may be applied simultaneously with
`
`magnetic treatment. The time consequences of the treatment are described
`
`below.
`
`66964-8034.US00/1340027741
`
`13
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`[0044]
`
`Figure 1 illustrates an exemplary embodiment providing combined
`
`treatment by magnetic field and optical
`
`treatment. The optical
`
`treatment
`
`is
`
`administered by optical treatment device 1 (dotted line) including a connection
`
`to an energy source 2 and a hardware panel 3 for controlling the optical
`
`treatment. The hardware panel 3 is connected with optical waves generating
`
`device 4 within an optical treatment applicator 5 (dotted line). The magnetic
`
`treatment is administered by magnetic treatment device 6 (dotted line) including
`
`a connection to an energy source 7 and a hardware panel 8 for controlling the
`
`treatment by magnetic field. The hardware panel 8 is connected with magnetic
`
`1O
`
`field generating device 9 within a magnetic treatment applicator 10 (dotted line).
`
`[0045]
`
`In an alternative embodiment
`
`the at
`
`least one optical waves
`
`generating device may be in the treatment device. The optical waves may be
`
`delivered to the applicator and/or to the target biological structure by a
`
`waveguide.
`
`15
`
`[0046]
`
`According to another embodiment the magnetic treatment and
`
`optical
`
`treatment may be provided by one device. The combined treatment
`
`provided by one device may be administered by at least one applicator. Figures
`
`2a and 2b illustrate exemplary embodiments providing the combined treatment
`
`by two applicators providing different types of treatment,
`
`i.e. magnetic and
`
`20
`
`optical treatment, to the target biological structure. Figures 3a and 3b illustrate
`
`exemplary embodiments providing the combined treatment by one applicator
`
`providing magnetic and/or optical treatment to the target biological structure.
`
`66964-8034.US00/134002774.1
`
`14
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`[0047]
`
`Figure 2a illustrates one exemplary embodiment of a combined
`
`treatment device providing magnetic and/or optical treatment by at least two
`
`applicators. The combined treatment device 11
`
`(dotted line)
`
`includes a
`
`connection to an energy source 12 providing energy for a magnetic treatment
`
`and for an optical treatment. The optical treatment is controlled by a hardware
`
`panel for optical
`
`treatment 13 which controls an optical waves generating
`
`device 14 within an optical treatment applicator 15 (dotted line). The magnetic
`
`treatment is controlled by a hardware panel for magnetic treatment 16 which
`
`controls a magnetic field generating device 17 within a magnetic treatment
`
`1O
`
`applicator 18 (dotted line).
`
`[0048]
`
`In an alternative embodiment
`
`the at
`
`least one optical waves
`
`generating device may be in the treatment device. The optical waves may be
`
`delivered to the applicator and/or to the target biological structure by a
`
`waveguide.
`
`15
`
`[0049]
`
`Figure 2b illustrates another exemplary embodiment of a
`
`treatment device providing magnetic and/or optical treatment by at least two
`
`applicators. The combined treatment device 19 (dotted line)
`
`includes a
`
`connection to an energy source 20 providing energy for the magnetic treatment
`
`and/or for
`
`the optical
`
`treatment. Optical and/or magnetic treatments are
`
`20
`
`controlled by a hardware panel 21. The hardware panel 21 controls an optical
`
`waves generating device 22 within an optical treatment applicator 23 (dotted
`
`line). Further the hardware panel 21 controls a magnetic field generating device
`
`24 within a magnetic treatment applicator 25 (dotted line).
`
`66964-8034.US00/1340027741
`
`15
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`[0050]
`
`In an alternative embodiment
`
`the optical waves generating
`
`devices may be in the treatment device. The optical waves may be delivered to
`
`the applicator and/or to the target biological structure by a waveguide.
`
`[0051]
`
`Figure 3a illustrates still another exemplary embodiment of a
`
`treatment device providing magnetic and/or optical treatment by at least one
`
`applicator. The combined treatment device 26 (dotted line)
`
`includes a
`
`connection to an energy source 27 providing energy for the magnetic treatment
`
`and/or for the optical
`
`treatment. The optical
`
`treatment
`
`is controlled by a
`
`hardware panel
`
`for optical
`
`treatment 28 which controls an optical waves
`
`1O
`
`generating device 29 within an applicator 30 (dotted line). The magnetic
`
`treatment is controlled by a hardware panel for magnetic treatment 31 which
`
`controls a magnetic field generating device 32 within the applicator 30 (dotted
`
`line). The applicator provides combined treatment.
`
`[0052]
`
`In an alternative embodiment
`
`the optical waves generating
`
`15
`
`devices may be in the treatment device. The optical waves may be delivered to
`
`the applicator and/or to the target biological structure by a waveguide.
`
`[0053]
`
`Figure 3b illustrates still another exemplary embodiment of a
`
`treatment device providing magnetic and/or optical treatment by at least one
`
`applicator. The combined treatment device 33 (dotted line)
`
`includes a
`
`20
`
`connection to an energy source 34 providing energy for the magnetic treatment
`
`and/or for the optical treatment. Optical and/or magnetic treatment is controlled
`
`by a hardware panel 35. The hardware panel 35 controls an optical waves
`
`66964-8034.US00/134002774.1
`
`16
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`generating device 36 and magnetic field generating device 37 within an
`
`applicator 38 (dotted line).
`
`[0054]
`
`In an alternative embodiment
`
`the at
`
`least one optical waves
`
`generating device may be in the treatment device. The optical waves may be
`
`delivered to the applicator and/or to the target biological structure by a
`
`waveguide.
`
`[0055]
`
`According to still
`
`another embodiment
`
`the magnetic field
`
`generating device may be used as an energy source for providing energy to
`
`another part of the treatment device, e.g. an optical waves generating device
`
`1O
`
`such as light-emitting diode (LED). Figures 4a and 4b illustrate exemplary
`
`embodiments of the magnetic field generating device which may be used as
`
`power supply. The magnetic field generating device 39 may be surrounded by a
`
`conductor loop 40. The time-varying magnetic field generated by magnetic field
`
`generating device 39 induces eddy currents in the conductor loop 40 within
`
`15
`
`proximity of the magnetic field generating device 39. The induced current in the
`
`conductor loop 40 may be used for providing energy to another powered part of
`
`the treatment device, particularly in the applicator, or another treatment device,
`
`such as at least one optical waves generating device. Figure 4a illustrates an
`
`exemplary embodiment of magnetic field generating device 39 surrounded by a
`
`20
`
`conductor loop 40. The conductor loop 40 may be connected to a plurality of
`
`optical waves generating devices 41. Figure 4b illustrates another exemplary
`
`embodiment of the magnetic field generating device 39 surrounded by the
`
`conductor loop 40. The conductor loop 40 provides the energy to the optical
`
`66964-8034.US00/1340027741
`
`17
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`waves generating device 41. The optical waves generating device may be
`
`distanced from the conductor loop and may be external
`
`to the applicator
`
`including the magnetic field generating device 39 and the conductor loop 40.
`
`[0056]
`
`Biocompatibility issues or hot spot generation may be overcome
`
`by transmitting electromagnetic energy into the target biological structure
`
`without physical contact with the patient. Contactless application of magnetic
`
`and/or optical treatments may provide sufficient passive cooling of the biological
`
`structure by circulating air.
`
`[0057]
`
`In some indications,
`
`it may be advantageous to treat deeper
`
`1O
`
`adipose tissue by magnetic field simultaneously with the treatment of more
`
`superficial layers of the skin by optical waves.
`
`[0058]
`
`An air gap or bolus material with high air permeability may be
`
`placed between the skin and the applicator. The material may be preferably
`
`transparent
`
`to the optical waves. This arrangement uses
`
`the human
`
`15
`
`thermoregulatory system for cooling and avoids the need of artificial cooling of
`
`the skin. Optionally, the skin may be cooled via a stream of chilled or ambient
`
`temperature air. The human thermoregulatory system enables perspiration and
`
`other body fluids to evaporate and cool the surrounding skin. The application of
`
`electromagnetic waves is contactless. Therefore sweat accumulation and/or hot
`
`20
`
`spot creation are avoided. Use of cooling fluids or gels is not necessary but may
`
`be optionally used. Cost of the treatment is reduced and patient comfort
`
`is
`
`improved. The applicator may be in direct or indirect contact with patients skin.
`
`A bolus device may be used for providing indirect contact of the applicator with
`
`66964-8034.US00/134002774.1
`
`18
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`the target biological structure. A bolus may be filled with a material, preferably a
`
`fluid,
`
`influencing the propagation of
`
`the electromagnetic waves and/or
`
`homogenizing the temperature distribution of the patient’s skin. Alternatively the
`
`bolus may deliver the electromagnetic waves to the target biological structure,
`
`e.g. a waveguide.
`
`[0059]
`
`Cooling may be provided by positioning an air moving device
`
`proximate to the skin. The air moving device may be attached to or
`
`implemented into the applicator. Air moving device may be any kind of fan,
`
`ventilator or blower. The blower may include an air tube connected to air source
`
`1O
`
`for moving air through the air tube to the patient’s skin. The air source may
`
`alternatively be cooled to provide cooled air. Alternatively, air suction may be
`
`also used as an active cooling method.
`
`[0060]
`
`There is no necessity of constant movement of the applicator over
`
`a larger area. The applicator may remain in a stationary position relative to the
`
`15
`
`patient for several seconds or longer, e.g. for at least 10, 30, 60, 120 or 240
`
`seconds, or longer. The at least one applicator may be of such dimension which
`
`may allow to the treated biological
`
`structure to be within physiological
`
`conditions, e.g.
`
`the biological structure may not be overheated over critical
`
`temperature causing irreversible changes in the biological structure.
`
`20
`
`[0061]
`
`The static position of the at least one applicator may be provided
`
`by a positioning member. The positioning member may be e.g. an arm or an
`
`adjustable flexible belt. The positioning member may include a buckle for
`
`adjusting the length of the belt. The applicator may be placed within predefined
`
`66964-8034.US00/134002774.1
`
`19
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`locations of the belt. Alternatively the applicator may be shaped to be moveable
`
`along the positioning member, e.g.
`
`the shape of
`
`the applicator may be
`
`preferably concave, e.g. V-shaped or U-shaped. The positioning member may
`
`be inserted itself into the concavity of the applicator. The position of the
`
`applicator may be adjusted by limited movement along the positioning member
`
`because the positioning member may be used as guiding member. However,
`
`the applicator may not be fixed to a particular static position. The position of the
`
`applicator may be dynamically adjusted during the treatment following the
`
`patient’s needs. The position of the applicator may be adjusted manually by the
`
`1O
`
`operator, or automatically by the treatment device.
`
`In one exemplary
`
`embodiment a plurality of applicators may be used for treating larger body part,
`
`e.g. buttocks, abdomen or thigh.
`
`[0062]
`
`Still other embodiments of positioning member may be found in
`
`provisional US patent application No. 62/375,796 incorporated herein by
`
`15
`
`reference.
`
`[0063]
`
`Alternatively the treatment may be provided by moving the
`
`applicator. The movement of the applicator may be manual or automatic. The
`
`automatic movement may be random or it may follow a predetermined pattern,
`
`e.g. an array, a matrix or predefined trajectory designed for the selected treated
`
`20
`
`part of the body or it may be adjusted following the patient’s needs. The
`
`movement of the applicator may be provided by an arm, which may be
`
`preferably articulated.
`
`66964-8034.US00/134002774.1
`
`20
`
`

`

`Attorney Dkt. N0. 066964-8034.USOO
`
`[0064]
`
`One or more applicators may move in the vicinity of the patient’s
`
`body. The movement may be provided in various speed and/or acceleration.
`
`It
`
`may be moved in at least one direction, e.g. longitudinal, vertical, transversal or
`
`different axis and/or by rotational movement around any direction. Plurality of
`
`applicators may move
`
`in
`
`synchronized,
`
`randomized and/or
`
`independent

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket